Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Tivic Health Systems Inc TIVC

Healthcare Medical Devices
Tivic Health Systems, Inc. is a commercial-stage health tech company advancing the field of bioelectronic medicine. The Company’s patented technology platform leverages stimulation on the trigeminal, sympathetic, and vagus nerve structures. Its non-invasive and targeted approach to the treatment of inflammatory chronic health conditions is intended to give consumers and providers drug-free... see more

Recent & Breaking News (NDAQ:TIVC)

Tivic Reports Third Quarter 2024 Financial Results and Provides Business Update

Business Wire 12 days ago

Enrollment Complete in Tivic Health Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device

Business Wire 13 days ago

Tivic Health Validates European Patents in Great Britain, Germany, and France

Business Wire November 12, 2024

Tivic Health Systems, Inc. to Report Third Quarter 2024 Financial Results on November 14

Business Wire November 7, 2024

First Subject Enrolled in Tivic Health's Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device

Business Wire October 29, 2024

Tivic Health CEO Jennifer Ernst to Present at New York BioFuture 2024

Business Wire October 24, 2024

Tivic Health Receives Approval from Institutional Review Board for ncVNS Optimization Study, Readies for Enrollment

Business Wire September 18, 2024

Tivic Health Accelerates VNS Commercial Strategy Development

Business Wire September 17, 2024

Tivic Health Appoints Lisa Wolf as Interim Chief Financial Officer

Business Wire September 13, 2024

Tivic Reports Second Quarter 2024 Financial Results

Business Wire August 14, 2024

Tivic Health to Report Q2 2024 Financial Results and Corporate Update on August 14th Via Conference Call and Webcast

Business Wire August 6, 2024

Tivic Announces 2024 Annual Meeting of Stockholders

Business Wire August 2, 2024

Tivic Health Expands Intellectual Property Portfolio

Business Wire July 23, 2024

Tivic Health: Christina Valauri Appointed to Board of Directors

Business Wire June 18, 2024

Tivic Health Partners with the Feinstein Institutes to Advance its Patent-pending, Non-Invasive Cervical Vagus Nerve Stimulation; Begins Optimization of ncVNS for use in Clinical Indications

Business Wire May 22, 2024

Tivic Reports First Quarter 2024 Financial Results and Subsequent Events

Business Wire May 15, 2024

Tivic Health to Report Q1 2024 Financial Results and Subsequent Events on May 15th Via Conference Call and Webcast

Business Wire May 13, 2024

Tivic Health Announces Closing of $4.0 Million Public Offering

Business Wire May 13, 2024

Tivic Health Announces Pricing of $4.0 Million Public Offering

Business Wire May 9, 2024

Tivic Health Announces Successful Completion of Non-Invasive Vagus Nerve Stimulation Study (VNS); Demonstrates Clinically Effective Biological Changes in the Autonomic, Cardiac, and Central Nervous Systems

Business Wire May 8, 2024